Muhammad Awais

Dr. Muhammad Awais


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Agriengineering
Verified
Journal Article
Open access
PDF file
DRDinesh Jackson Samuel Ravindran
Dinesh Jackson Samuel Ravindran
ISInna Skarga-Bandurova
Inna Skarga-Bandurova
SVSIVAKUMAR V
SIVAKUMAR V
MAMuhammad Awais
Muhammad Awais
MSMithra S
Mithra S
Large language models (LLMs) offer new opportunities for agricultural education and decision support, yet their adoption is limited by domain-specific terminology, ambiguous retrieval, and factual inconsistencies. This work presents AgroLLM, a domain-governed agricultural knowledge system that integrates structured textbook-derived knowledge with Retrieval-Augmented Generation (RAG) and a Domain Knowledge Processing Layer (DKPL). The DKPL contributes symbolic domain concepts, causal rules, and agronomic thresholds that guide retrieval and validate model outputs. A curated corpus of nineteen agricultural textbooks was converted into semantically annotated chunks and embedded using Gemini, OpenAI, and Mistral models. Performance was evaluated using a 504-question benchmark aligned with four FAO/USDA domain categories. Three LLMs (Mistral-7B, Gemini 1.5 Flash, and ChatGPT-4o Mini) were assessed for retrieval quality, reasoning accuracy, and DKPL consistency. Results show that ChatGPT-4o Mini with DKPL-constrained RAG achieved the highest accuracy (95.2%), with substantial reductions in hallucinations and numerical violations. The study demonstrates that embedding structured domain knowledge into the RAG pipeline significantly improves factual consistency and produces reliable, context-aware agricultural recommendations. AgroLLM offers a reproducible foundation for developing trustworthy AI-assisted learning and advisory tools in agriculture.

28 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RPRamesh Paudyal
Ramesh Paudyal
ALAlfonso Lema-Dopico
Alfonso Lema-Dopico
ASAkash Deelip Shah
Akash Deelip Shah
VHVaios Hatzoglou
Vaios Hatzoglou
MAMuhammad Awais
Muhammad Awais
ASAmita Shukla-Dave
Amita Shukla-Dave
Background/Objectives: This work prospectively evaluates the vendor-provided Low Variance (LOVA) apparent diffusion coefficient (ADC) gradient nonlinearity correction (GNC) technique for primary tumors, neck nodal metastases, and normal masseter muscles in patients with head and neck cancers (HNCs). Methods: Multiple b-value diffusion-weighted (DW)-MR images were acquired on a 3.0 T scanner using a single-shot echo planar imaging (SS-EPI) and multi-shot (MS)-EPI for diffusion phantom materials (20% and 40% polyvinylpyrrolidone (PVP) in water). Pretreatment DW-MRI acquisitions were performed for sixty HNC patients (n = 60) who underwent chemoradiation therapy. ADC values with and without GNC were calculated offline using a monoexponential diffusion model over all b-values, relative percentage (r%) changes (Δ) in ADC values with and without GNC were calculated, and the ADC histograms were analyzed. Results: Mean ADC values calculated using SS-EPI DW data with and without GNC differed by ≤1% for both PVP20% and PVP40% at the isocenter, whereas off-center differences were ≤19.6% for both concentrations. A similar trend was observed for these materials with MS-EPI. In patients, the mean rΔADC (%) values measured with SS-EPI differed by 4.77%, 3.98%, and 5.68% for primary tumors, metastatic nodes, and masseter muscle. MS-EPI exhibited a similar result with 5.56%, 3.95%, and 4.85%, respectively. Conclusions: This study showed that the GNC method improves the robustness of the ADC measurement, enhancing its value as a quantitative imaging biomarker used in HNC clinical trials.

15 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
RPRamesh Paudyal
Ramesh Paudyal
JRJames Russell
James Russell
HLH Carl LeKaye
H Carl LeKaye
JDJoseph O. Deasy
Joseph O. Deasy
JHJohn L. Humm
John L. Humm
ASAmita Shukla-Dave
Amita Shukla-Dave
Background/Objectives: The tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) is characterized by an enriched stroma, hampering the effectiveness of therapy. This co-clinical study aimed to (1) provide insight into early post-treatment changes in the TME using multiparametric magnetic resonance imaging (mpMRI)-derived quantitative imaging biomarkers (QIBs) in a preclinical PDAC model treated with radiotherapy and correlate these QIBs with histology; (2) evaluate the feasibility of obtaining these QIBs in patients with PDAC using clinically approved mpMRI data acquisitions. Methods: Athymic mice (n = 12) at pre- and post-treatment as well as patients with PDAC (n = 11) at pre-treatment underwent mpMRI including diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) data acquisition sequences. DW and DCE data were analyzed using monoexponential and extended Tofts models, respectively. DeepLIIF quantified the total percentage (%) of tumor cells in hematoxylin and eosin (H&E)-stained tissues from athymic mice. Spearman correlation and Wilcoxon signed rank tests were performed for statistical analysis. Results: In the preclinical PDAC model, mean pre- and post-treatment ADC and Ktrans values differed significantly (p < 0.01), changing by 20.50% and 20.41%, respectively, and the median total tumor cells quantified by DeepLIIF was 24% (range: 15–53%). Post-treatment ADC values and relative change in ve (rΔve) showed a significant negative correlation with total tumor cells (ρ = −0.77, p < 0.014 for ADC and ρ = −0.77, p = 0.009 for rΔve). In patients with PDAC, pre-treatment mean ADC and Ktrans values were 1.76 × 10−3 (mm2/s) and 0.24 (min−1), respectively. Conclusions: QIBs in both preclinical and clinical settings underscore their potential for future co-clinical research to evaluate emerging drug combinations targeting both tumor and stroma.